Skip to content

Mar 2017, Volume 24, Issue 2

March’s edition of the EJHP includes an editorial on “Value or cost”, and original articles on: evaluation of a pharmaceutical assessment screening tool; biosimilar infliximab for the management of rheumatoid arthritis; the cost and efficiency of incident reporting in a specialist paediatric NHS hospital and impact on patient safety; ready-to-use parenteral amiodarone; and much more.

The edition also contains a case report on bradycardia associated with pegylated liposomal doxorubicin administration, as well as a postcript on deprescribing in India: will we ever get down to it?. 

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.